[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Skelton et al., 1986 - Google Patents

Problems of intensive therapy in childhood cancer

Skelton et al., 1986

View PDF
Document ID
8222178173581025522
Author
Skelton J
Pizzo P
Publication year
Publication venue
Cancer

External Links

Snippet

Tremendous progress has been made in the treatment of childhood cancers. Certain hematologic malignancies have an impressive cure rate with the current intensive antineoplastic treatment regimens. There is optimism that the treatment of children who have …
Continue reading at acsjournals.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations

Similar Documents

Publication Publication Date Title
Miyakawa et al. Thiolactomycin, a new antibiotic IV. Biological properties and chemotherapeutic activity in mice
WAISBREN et al. A clinical appraisal of neomycin
Cudmore et al. Clostridium difficile colitis associated with cancer chemotherapy
KARP et al. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia: a randomized, double-blind, placebo-controlled trial
Warner et al. Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess
Finland et al. Clinical and laboratory observations of a new antibiotic, tetracycline
Fernbach et al. Inhibition of the mixed lymphocyte culture by peritoneal exudate cells
ES2334774T3 (en) TREATMENT OF CHRONIC, RESISTANT OR INTOLERANTEAL LEUKEMIA STI571, WHICH CONSISTS IN HOMOHARRIGTONINE ONLY OR COMBINED WITH OTHER AGENTS.
Becton et al. An experience with an implanted port system in 66 children with cancer
Frank et al. Traumatic shock: XXI. Effectiveness of an antibiotic in experimental hemorrhagic shock
Neu Clinical role of Pseudomonas aeruginosa
Skelton et al. Problems of intensive therapy in childhood cancer
Neu Fosfomycin Trometamol versus Amoxycillin-Single-Dose Multicenter Study of Urinary Tract Infections.
Blasi et al. Biomolecular events involved in anticryptococcal resistance in the brain
Hagenbeek et al. High-dose cyclophosphamide treatment of acute myelocytic leukemia. Studies in the BNML rat model
Bacon et al. In vitro synergy studies with Clostridium difficile
Medoff et al. Response of Transplanted AKR Leukemia to Combination Therapy With Amphotericin Band 1, 3-Bis (2-chloroethyl)-1-nitrosourea: Dose and Schedule Dependency
Welch et al. Penicillin X: Successful treatment of gonorrhea with a single intramuscular injection
Gentry Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overview
McCabe Bacterial interference induced in embryonated eggs by staphylococci
Baquero et al. Antibiotherapy of Serratia marcescens septicemia in children.
Collins et al. Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo
Vallée et al. Pharmacokinetics of four fluoroquinolones in an animal model of infected lung
Chao et al. A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma
Meyers et al. Bacteriological, pharmacological, and clinical studies of carbenicillin